• Science & Technology
• Health & Medicine

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment. Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

21 September 2021

• Science & Technology
• Health & Medicine

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

19 September 2021

• Health & Medicine

New chemotherapy-free treatment for bowel cancer made available in Scotland

Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.   Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.  

14 September 2021

• Health & Medicine

Hormone therapy gets green light for advanced prostate cancer

Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option. Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option.

14 September 2021

• Health & Medicine

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer. The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

10 September 2021

• Health & Medicine
• Policy & Insight

Opinion: ‘The idea that a tobacco company might profit off my disease appals me’

Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura. Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura.

1 September 2021

• Policy & Insight
• Health & Medicine

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage. During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

27 August 2021

• Health & Medicine

Smoking among young adults increased by 25% during first lockdown

Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown. Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown.

25 August 2021

• Health & Medicine
• Science & Technology

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

24 August 2021

• Health & Medicine
• Policy & Insight

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role. Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

19 August 2021

• Health & Medicine
• Science & Technology

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021